| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.30e-06 | 11 | 204 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | MFAP2 ACAN AMELY COL6A3 COL7A1 COL15A1 CILP LAMA4 TECTA ENAM | 2.45e-05 | 188 | 204 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.63e-05 | 42 | 204 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | latrotoxin receptor activity | 1.04e-04 | 2 | 204 | 2 | GO:0016524 | |
| GeneOntologyMolecularFunction | cholesterol dehydrogenase activity | 1.04e-04 | 2 | 204 | 2 | GO:0102294 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.04e-04 | 32 | 204 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | actin binding | MAP1A MYO10 CEACAM8 CORO2B SYN1 DNASE1 PLS1 FLNA FLNC HDAC6 MYH7B LRPPRC ABLIM2 EPB41 | 4.29e-04 | 479 | 204 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | CDC14C PALD1 PIWIL1 ZC3H12B PLA2G2F PPM1J NDST3 FASN CILP2 PTPRN2 SULF1 DNASE1 PLCZ1 CILP CDC14B ABHD5 G6PC3 LRRD1 PIWIL3 | 6.41e-04 | 807 | 204 | 19 | GO:0016788 |
| GeneOntologyMolecularFunction | protein kinase binding | PIWIL1 CEACAM8 LYST NEK9 POTEE SHC2 NFATC1 PIK3R1 NBEAL2 CPNE3 SYN1 LRRC7 FLNA POTEF DOK7 CD6 CSPG4 POTEJ POTEI PRLR | 6.49e-04 | 873 | 204 | 20 | GO:0019901 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZEB2 OVOL2 HOXC4 CSRNP3 NFATC1 NFIX DLX2 DMRT1 SOX30 RUNX1 TFAP2B TFAP2C ZIC1 ZIC2 PBX2 | 6.66e-04 | 560 | 204 | 15 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZEB2 OVOL2 HOXC4 CSRNP3 NFATC1 NFIX DLX2 DMRT1 SOX30 RUNX1 TFAP2B TFAP2C ZIC1 ZIC2 PBX2 | 7.42e-04 | 566 | 204 | 15 | GO:0001216 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 9.02e-04 | 19 | 204 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | kinase binding | PIWIL1 CEACAM8 LYST NEK9 POTEE SHC2 NFATC1 PIK3R1 NBEAL2 CPNE3 SYN1 LRRC7 FLNA POTEF DOK7 OPA1 CD6 CSPG4 POTEJ POTEI PRLR | 9.66e-04 | 969 | 204 | 21 | GO:0019900 |
| GeneOntologyBiologicalProcess | cell morphogenesis | HEXB TNIK PRTG MAP1A MYO10 FSTL4 CDH23 PTCH1 SS18 ZEB2 POTEE MFAP2 FAT1 SEMA6D NFIX NBEAL2 VPS13A DMRT1 PLS1 FLNA HDAC6 KALRN POTEF MINK1 L1CAM TECTA OPA1 ZIC2 ENAM EPHA2 POTEJ POTEI EPB41 EPHA3 EPHA5 | 5.24e-09 | 1194 | 202 | 35 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | TNIK PRTG MAP1A FSTL4 CDH23 TSC1 PTCH1 ZEB2 POTEE NF1 SEMA6D ALMS1 WASHC5 NFIX VPS13A SYN1 LRRC7 PLS1 FLNA HDAC6 KALRN POTEF MINK1 L1CAM RAPGEF1 RUNX1 TECTA OPA1 ZIC2 TENM3 TMEM132E CSPG4 TENM1 POTEJ POTEI PBX2 EPHA3 EPHA5 | 2.74e-08 | 1463 | 202 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | TNIK PRTG MAP1A FSTL4 CDH23 TSC1 PTCH1 ZEB2 POTEE NF1 SEMA6D ALMS1 WASHC5 NFIX VPS13A LRRC7 PLS1 FLNA HDAC6 KALRN POTEF MINK1 L1CAM RAPGEF1 TECTA OPA1 ZIC2 TENM3 CSPG4 POTEJ POTEI EPHA3 EPHA5 | 3.39e-07 | 1285 | 202 | 33 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PRTG HLA-DOA MYO10 PKD1L1 CEACAM8 CDH23 PLA2G2F ITGAM FAT1 VPS33B PIK3R1 MAD1L1 LRRC7 ADGRL3 FLNA PCDHGA7 PCDHGA6 MINK1 L1CAM ITGA10 RAPGEF1 ADGRL1 RUNX1 OPA1 CD6 TENM3 ARID2 TENM1 EPHA3 | 7.41e-07 | 1077 | 202 | 29 | GO:0098609 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | STARD13 TNIK TSC1 ZEB2 POTEE FAT1 CORO2B NF1 ALMS1 WASHC5 PIK3R1 PLS1 FLNA FLNC HDAC6 POTEF MINK1 BAG4 TENM1 POTEJ POTEI EPB41 EPHA3 EPHA5 | 1.23e-06 | 803 | 202 | 24 | GO:0030036 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TNIK PRTG MAP1A FSTL4 CDH23 PTCH1 ZEB2 POTEE SEMA6D NFIX PLS1 HDAC6 KALRN POTEF MINK1 L1CAM TECTA OPA1 ZIC2 POTEJ POTEI EPHA3 EPHA5 | 1.29e-06 | 748 | 202 | 23 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PRTG CEACAM8 CDH23 ITGAM FAT1 ADGRL3 PCDHGA7 PCDHGA6 L1CAM ADGRL1 CD6 TENM3 TENM1 EPHA3 | 2.71e-06 | 313 | 202 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | actin filament-based process | STARD13 TNIK TSC1 ZEB2 POTEE FAT1 CORO2B NF1 ALMS1 WASHC5 PIK3R1 PLS1 FLNA FLNC HDAC6 MYH7B POTEF MINK1 BAG4 TENM1 POTEJ POTEI EPB41 EPHA3 EPHA5 | 3.40e-06 | 912 | 202 | 25 | GO:0030029 |
| GeneOntologyBiologicalProcess | synapse organization | TSC1 ITGAM POTEE NF1 PIK3R1 SYN1 ADGRL2 ADGRL3 FLNA HDAC6 KALRN POTEF DOK7 L1CAM ADGRL1 OPA1 TENM3 POTEJ POTEI EPHA3 EPHA5 | 4.02e-06 | 685 | 202 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | CEACAM8 CDH23 EXT2 PTCH1 OVOL2 MFAP2 FAT1 HOXC4 HOXC9 NF1 ALMS1 NFATC1 VPS33B SULF1 NFIX ACAN DLX2 PLS1 AMELY FLNA TECTA TFAP2C ZIC1 ENAM FGF23 NPHP3 TENM3 EPHA2 ARID2 PBX2 | 6.55e-06 | 1269 | 202 | 30 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | CDH23 TSC1 EXT2 PTCH1 ZEB2 OVOL2 SP8 MFAP2 HOXC4 HOXC9 SULF1 DLX2 HECTD1 PLS1 TECTA OPA1 ZIC1 ZIC2 NPHP3 EPHA2 PBX2 | 7.43e-06 | 713 | 202 | 21 | GO:0048598 |
| GeneOntologyBiologicalProcess | limbic system development | 1.06e-05 | 141 | 202 | 9 | GO:0021761 | |
| GeneOntologyBiologicalProcess | hippocampus development | 1.12e-05 | 108 | 202 | 8 | GO:0021766 | |
| GeneOntologyBiologicalProcess | pallium development | TSC1 ZEB2 NF1 NFIX DLX2 HSD3B1 HSD3B2 FLNA TFAP2C ZIC1 EPHA5 | 1.26e-05 | 222 | 202 | 11 | GO:0021543 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | HLA-DOA MYO10 CEACAM8 TSC1 PLA2G2F CORO2B NF1 VPS33B PIK3R1 MAD1L1 FLNA MINK1 L1CAM BAG4 LAMA4 RUNX1 OPA1 CD6 TENM3 EPHA2 ARID2 PRLR EPHA3 EPHA5 | 1.40e-05 | 927 | 202 | 24 | GO:0030155 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FSTL5 CEACAM8 FSTL4 SS18 ZEB2 OVOL2 SHC2 SULF1 PIK3R1 VPS13A CPNE3 DMRT1 EIF2AK3 CILP KALRN DOK7 RAPGEF1 GPRC5A TFAP2B OPA1 ZIC2 MST1R FGF23 EPHA2 CSPG4 PRLR EPHA3 EPHA5 | 1.41e-05 | 1186 | 202 | 28 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | CEACAM8 FSTL4 SS18 SHC2 SULF1 PIK3R1 VPS13A CPNE3 EIF2AK3 CILP KALRN RAPGEF1 GPRC5A OPA1 MST1R FGF23 EPHA2 CSPG4 PRLR EPHA3 EPHA5 | 1.50e-05 | 747 | 202 | 21 | GO:0007169 |
| GeneOntologyBiologicalProcess | regulation of protein localization | TNIK MAP1A PTCH1 ITGAM CORO2B NF1 UBXN2B PIK3R1 HECTD1 EIF2AK3 PLS1 FLNA HDAC6 KALRN DOK7 BAG4 RFX3 TFAP2B ZIC1 CEMIP EPHA2 PRKAA2 TENM1 EPB41 EPHA3 EPHA5 | 2.36e-05 | 1087 | 202 | 26 | GO:0032880 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TNIK MYO10 FSTL4 TSC1 ZEB2 NF1 SEMA6D WASHC5 PIK3R1 LRRC7 PLS1 FLNA HDAC6 KALRN L1CAM RAPGEF1 OPA1 TENM3 EPHA2 CSPG4 TENM1 EPHA3 | 3.06e-05 | 846 | 202 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | cell junction organization | TSC1 ITGAM POTEE CORO2B NF1 PIK3R1 SYN1 ADGRL2 ADGRL3 FLNA HDAC6 KALRN POTEF DOK7 L1CAM RAPGEF1 ADGRL1 OPA1 TENM3 EPHA2 POTEJ POTEI EPHA3 EPHA5 | 3.12e-05 | 974 | 202 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CDC14C TNIK MYO10 ALMS1 PIK3R1 CIBAR2 PLS1 FLNA HDAC6 MINK1 BAG4 RFX3 CDC14B NPHP3 WDR11 EPHA2 CSPG4 TENM1 ABLIM2 | 3.46e-05 | 670 | 202 | 19 | GO:0120031 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 3.50e-05 | 63 | 202 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TNIK MYO10 FSTL4 TSC1 ZEB2 NF1 SEMA6D WASHC5 PIK3R1 LRRC7 PLS1 FLNA HDAC6 KALRN L1CAM RAPGEF1 OPA1 TENM3 EPHA2 CSPG4 TENM1 EPHA3 | 4.12e-05 | 863 | 202 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TNIK PRTG MAP1A FSTL4 PTCH1 ZEB2 POTEE SEMA6D NFIX VPS13A HDAC6 KALRN POTEF MINK1 L1CAM OPA1 ZIC2 POTEJ POTEI EPHA3 EPHA5 | 4.24e-05 | 802 | 202 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | PRTG MAP1A FSTL4 PTCH1 ZEB2 POTEE SEMA6D NFIX HDAC6 KALRN POTEF L1CAM ZIC2 POTEJ POTEI EPHA3 EPHA5 | 4.48e-05 | 566 | 202 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | TNIK PRTG FSTL4 ZEB2 NF1 SEMA6D PIK3R1 ACAN DLX2 ADGRL2 EIF2AK3 IL33 ADGRL3 HDAC6 KALRN L1CAM ADGRL1 OPA1 | 4.60e-05 | 625 | 202 | 18 | GO:0051960 |
| GeneOntologyBiologicalProcess | cell projection assembly | CDC14C TNIK MYO10 ALMS1 PIK3R1 CIBAR2 PLS1 FLNA HDAC6 MINK1 BAG4 RFX3 CDC14B NPHP3 WDR11 EPHA2 CSPG4 TENM1 ABLIM2 | 4.66e-05 | 685 | 202 | 19 | GO:0030031 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | TNIK MAP1A PTCH1 ITGAM CORO2B NF1 UBXN2B PIK3R1 HECTD1 EIF2AK3 PLS1 DYNC1H1 FLNA HDAC6 KALRN DOK7 BAG4 RFX3 TFAP2B ZIC1 CEMIP EPHA2 PRKAA2 TENM1 EPB41 EPHA3 EPHA5 | 5.57e-05 | 1212 | 202 | 27 | GO:0060341 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TNIK PRTG MAP1A FSTL4 PTCH1 ZEB2 POTEE SEMA6D NFIX VPS13A HDAC6 KALRN POTEF MINK1 L1CAM OPA1 ZIC2 POTEJ POTEI EPHA3 EPHA5 | 5.73e-05 | 819 | 202 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TNIK PRTG MAP1A FSTL4 PTCH1 ZEB2 POTEE SEMA6D NFIX VPS13A HDAC6 KALRN POTEF MINK1 L1CAM OPA1 ZIC2 POTEJ POTEI EPHA3 EPHA5 | 6.46e-05 | 826 | 202 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | axon development | PRTG MAP1A FSTL4 PTCH1 ZEB2 POTEE SEMA6D NFIX FLNA HDAC6 KALRN POTEF L1CAM ZIC2 POTEJ POTEI EPHA3 EPHA5 | 6.48e-05 | 642 | 202 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | epithelium development | STARD13 CDH23 TSC1 PTCH1 ZEB2 OVOL2 FASN FAT1 NF1 ALMS1 NFATC1 SULF1 NFIX DMRT1 HECTD1 PLS1 FLNA RAPGEF1 RUNX1 TECTA RFX3 TFAP2B TFAP2C OPA1 ZIC2 ENAM NPHP3 TMEM132E EPHA2 PRLR | 1.01e-04 | 1469 | 202 | 30 | GO:0060429 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | TNIK ZEB2 NF1 WASHC5 PIK3R1 LRRC7 FLNA HDAC6 KALRN L1CAM RAPGEF1 OPA1 TENM3 TENM1 EPHA3 | 1.13e-04 | 494 | 202 | 15 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TNIK FSTL4 TSC1 ZEB2 NF1 SEMA6D WASHC5 LRRC7 FLNA HDAC6 KALRN L1CAM RAPGEF1 OPA1 TENM3 CSPG4 EPHA3 | 1.16e-04 | 612 | 202 | 17 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 1.21e-04 | 237 | 202 | 10 | GO:1905475 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | STARD13 TSC1 PTCH1 ZEB2 OVOL2 FAT1 ALMS1 NFATC1 SULF1 HECTD1 FLNA RUNX1 TFAP2C OPA1 ZIC2 NPHP3 EPHA2 | 1.33e-04 | 619 | 202 | 17 | GO:0002009 |
| GeneOntologyBiologicalProcess | embryonic organ development | CDH23 PTCH1 OVOL2 MFAP2 HOXC4 HOXC9 DLX2 HECTD1 PLS1 RUNX1 TECTA ZIC1 NPHP3 EPHA2 ARID2 PBX2 | 1.37e-04 | 561 | 202 | 16 | GO:0048568 |
| GeneOntologyBiologicalProcess | embryo development | CDH23 TSC1 EXT2 PTCH1 ZEB2 OVOL2 SP8 MFAP2 HOXC4 HOXC9 NF1 SULF1 LRRC7 DLX2 HECTD1 PLS1 LAMA4 RUNX1 CUBN TECTA TFAP2C OPA1 ZIC1 ZIC2 NPHP3 SF3B1 EPHA2 ARID2 PBX2 | 1.64e-04 | 1437 | 202 | 29 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TNIK TSC1 ZEB2 NF1 ALMS1 WASHC5 PIK3R1 CDC16 MAD1L1 LRRC7 DMRT1 ADGRL2 DYNC1H1 ADGRL3 FLNA HDAC6 KALRN L1CAM BAG4 RAPGEF1 ADGRL1 RUNX1 OPA1 TENM3 EPHA2 TENM1 RIMBP2 EPHA3 | 1.66e-04 | 1366 | 202 | 28 | GO:0051130 |
| GeneOntologyBiologicalProcess | neural tube development | 1.76e-04 | 202 | 202 | 9 | GO:0021915 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 1.82e-04 | 120 | 202 | 7 | GO:0014020 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.84e-04 | 54 | 202 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | HLA-DOA TSC1 ITGAM ITK FASN NFATC1 PIK3R1 NFIX VPS13A HECTD1 IL33 SLAMF9 MINK1 RUNX1 OPA1 ARID2 LY9 | 1.98e-04 | 640 | 202 | 17 | GO:1903131 |
| GeneOntologyBiologicalProcess | pattern specification process | PKD1L1 PTCH1 ITGAM ZEB2 OVOL2 SP8 HOXC4 HOXC9 DLX2 RFX3 ZIC1 ZIC2 NPHP3 SF3B1 PBX2 | 2.23e-04 | 526 | 202 | 15 | GO:0007389 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.28e-04 | 31 | 202 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell proliferation | 2.59e-04 | 32 | 202 | 4 | GO:2000647 | |
| GeneOntologyBiologicalProcess | postsynapse organization | POTEE NF1 ADGRL3 HDAC6 KALRN POTEF DOK7 OPA1 POTEJ POTEI EPHA5 | 2.75e-04 | 313 | 202 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | regionalization | PKD1L1 PTCH1 ITGAM ZEB2 OVOL2 SP8 HOXC4 HOXC9 DLX2 RFX3 ZIC2 NPHP3 SF3B1 PBX2 | 2.76e-04 | 478 | 202 | 14 | GO:0003002 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | STARD13 TSC1 EXT2 PTCH1 ZEB2 OVOL2 MFAP2 NF1 SARS1 NFATC1 SULF1 NFIX NBEAL2 HECTD1 EIF2AK3 AMELY FLNA FLNC COL15A1 SOX30 RUNX1 TFAP2C OPA1 ZIC2 ENAM SF3B1 EPHA2 CSPG4 EPHA5 | 2.79e-04 | 1483 | 202 | 29 | GO:0048646 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | TNIK PTCH1 PIK3R1 LRRC7 HECTD1 PLS1 FLNA KALRN BAG4 PREPL EPHA2 EPB41 EPHA3 | 2.82e-04 | 422 | 202 | 13 | GO:1990778 |
| GeneOntologyBiologicalProcess | platelet alpha granule organization | 2.84e-04 | 3 | 202 | 2 | GO:0070889 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 2.90e-04 | 171 | 202 | 8 | GO:1904375 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | HLA-DOA TSC1 ITGAM ITK FASN NF1 NFATC1 PIK3R1 NFIX VPS13A HECTD1 IL33 SLAMF9 MINK1 RUNX1 OPA1 EPHA2 ARID2 LY9 | 2.90e-04 | 789 | 202 | 19 | GO:0002521 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 2.98e-04 | 130 | 202 | 7 | GO:1905477 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.44e-04 | 270 | 202 | 10 | GO:0007160 | |
| GeneOntologyBiologicalProcess | neural tube formation | 3.58e-04 | 134 | 202 | 7 | GO:0001841 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | TNIK PTCH1 PIK3R1 LRRC7 HECTD1 PLS1 FLNA BAG4 PREPL EPHA2 EPHA3 | 3.68e-04 | 324 | 202 | 11 | GO:0072659 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.69e-04 | 35 | 202 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 3.86e-04 | 97 | 202 | 6 | GO:0006029 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | ITGAM MFAP2 FASN NF1 NFATC1 VPS33B PIK3R1 NFIX NBEAL2 VPS13A IL33 FLNA HDAC6 RUNX1 EPHA2 | 4.16e-04 | 558 | 202 | 15 | GO:0030099 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | STARD13 TSC1 EXT2 PTCH1 ZEB2 OVOL2 FAT1 ALMS1 NFATC1 SULF1 HECTD1 FLNA RUNX1 TFAP2C OPA1 ZIC2 NPHP3 EPHA2 | 4.37e-04 | 750 | 202 | 18 | GO:0048729 |
| GeneOntologyBiologicalProcess | telencephalon development | TSC1 ZEB2 NF1 NFIX DLX2 HSD3B1 HSD3B2 FLNA TFAP2C ZIC1 EPHA5 | 4.52e-04 | 332 | 202 | 11 | GO:0021537 |
| GeneOntologyBiologicalProcess | exit from mitosis | 4.58e-04 | 37 | 202 | 4 | GO:0010458 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 4.58e-04 | 37 | 202 | 4 | GO:0009954 | |
| GeneOntologyBiologicalProcess | collateral sprouting | 4.58e-04 | 37 | 202 | 4 | GO:0048668 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.27e-04 | 187 | 202 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 5.85e-04 | 190 | 202 | 8 | GO:0016331 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 6.06e-04 | 191 | 202 | 8 | GO:0051017 | |
| GeneOntologyBiologicalProcess | response to corticosterone | 6.78e-04 | 18 | 202 | 3 | GO:0051412 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | STARD13 TSC1 PTCH1 ZEB2 OVOL2 NF1 SARS1 NFATC1 SULF1 HECTD1 EIF2AK3 FLNA COL15A1 RUNX1 TFAP2B TFAP2C OPA1 ZIC2 NPHP3 EPHA2 ARID2 CSPG4 EPHA5 | 6.85e-04 | 1125 | 202 | 23 | GO:0035239 |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 6.94e-04 | 195 | 202 | 8 | GO:0061572 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | CDH23 OVOL2 MFAP2 HOXC4 HOXC9 DLX2 PLS1 TECTA ZIC1 NPHP3 EPHA2 | 7.17e-04 | 351 | 202 | 11 | GO:0048562 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | MAP1A ITGAM CORO2B PIK3R1 EIF2AK3 PLS1 FLNA DOK7 ZIC1 CEMIP EPHA2 PRKAA2 TENM1 EPB41 EPHA3 | 7.50e-04 | 591 | 202 | 15 | GO:1903829 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 8.07e-04 | 249 | 202 | 9 | GO:0010976 | |
| GeneOntologyBiologicalProcess | response to mineralocorticoid | 8.17e-04 | 43 | 202 | 4 | GO:0051385 | |
| GeneOntologyBiologicalProcess | neural tube closure | 8.68e-04 | 113 | 202 | 6 | GO:0001843 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | TNIK ZEB2 PIK3R1 ACAN ADGRL2 IL33 ADGRL3 HDAC6 KALRN L1CAM ADGRL1 OPA1 | 8.93e-04 | 418 | 202 | 12 | GO:0051962 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 9.02e-04 | 76 | 202 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | tube closure | 9.09e-04 | 114 | 202 | 6 | GO:0060606 | |
| GeneOntologyBiologicalProcess | hemopoiesis | HLA-DOA TSC1 ITGAM ITK MFAP2 FASN NF1 NFATC1 VPS33B PIK3R1 NFIX NBEAL2 VPS13A HECTD1 IL33 FLNA HDAC6 SLAMF9 MINK1 RUNX1 OPA1 EPHA2 ARID2 LY9 | 9.24e-04 | 1223 | 202 | 24 | GO:0030097 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | STARD13 TSC1 PTCH1 ZEB2 OVOL2 NFATC1 HECTD1 TFAP2C OPA1 ZIC2 NPHP3 EPHA2 | 9.50e-04 | 421 | 202 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 9.91e-04 | 159 | 202 | 7 | GO:0001838 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 1.05e-03 | 312 | 202 | 10 | GO:0002573 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.11e-03 | 162 | 202 | 7 | GO:0030879 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO10 STK17B TSC1 POTEE CORO2B LRRC7 PLS1 FLNA FLNC KALRN MYH7B POTEF MSRA MST1R POTEJ POTEI ABLIM2 EPB41 EPHA3 | 4.97e-06 | 576 | 207 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | axon | PRTG MAP1A TSC1 PTCH1 POTEE NF1 PTPRN2 SYN1 LRRC7 DYNC1H1 ADGRL3 FLNA HDAC6 POTEF MINK1 L1CAM ADGRL1 OPA1 TENM3 PRKAA2 RIMBP2 POTEJ POTEI EPHA5 | 8.87e-06 | 891 | 207 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 8.03e-05 | 45 | 207 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.70e-04 | 32 | 207 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.70e-04 | 32 | 207 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | extracellular matrix | OLFML2A MFAP2 SEMA6D SULF1 ACAN AMELY COL6A3 COL7A1 COL15A1 CILP L1CAM LAMA4 RUNX1 TECTA ENAM ADAMTS7 CSPG4 | 3.01e-04 | 656 | 207 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | OLFML2A MFAP2 SEMA6D SULF1 ACAN AMELY COL6A3 COL7A1 COL15A1 CILP L1CAM LAMA4 RUNX1 TECTA ENAM ADAMTS7 CSPG4 | 3.12e-04 | 658 | 207 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | mitochondrial crista | 5.87e-04 | 17 | 207 | 3 | GO:0030061 | |
| GeneOntologyCellularComponent | actin filament | 6.41e-04 | 146 | 207 | 7 | GO:0005884 | |
| Domain | Latrophilin | 1.27e-06 | 3 | 203 | 3 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 1.27e-06 | 3 | 203 | 3 | IPR003334 | |
| Domain | - | PRTG HLA-DOA FSTL5 CEACAM8 FSTL4 CILP2 NFATC1 FLNA COL6A3 FLNC COL7A1 SLAMF9 CILP KALRN L1CAM MST1R EPHA2 RIMBP2 LY9 PRLR EPHA3 EPHA5 | 3.45e-06 | 663 | 203 | 22 | 2.60.40.10 |
| Domain | FN3 | PRTG COL6A3 FLNC COL7A1 KALRN L1CAM EPHA2 RIMBP2 PRLR EPHA3 EPHA5 | 5.91e-06 | 185 | 203 | 11 | SM00060 |
| Domain | Ank | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTED POTEC POTEM POTEJ POTEI | 7.76e-06 | 228 | 203 | 12 | PF00023 |
| Domain | OLF | 8.97e-06 | 13 | 203 | 4 | PF02191 | |
| Domain | OLF | 8.97e-06 | 13 | 203 | 4 | PS51132 | |
| Domain | Olfac-like_dom | 8.97e-06 | 13 | 203 | 4 | IPR003112 | |
| Domain | OLF | 8.97e-06 | 13 | 203 | 4 | SM00284 | |
| Domain | Ig-like_fold | PRTG HLA-DOA FSTL5 CEACAM8 FSTL4 CILP2 NFATC1 FLNA COL6A3 FLNC COL7A1 SLAMF9 CILP KALRN L1CAM MST1R EPHA2 RIMBP2 LY9 PRLR EPHA3 EPHA5 | 9.34e-06 | 706 | 203 | 22 | IPR013783 |
| Domain | Gal_Lectin | 1.25e-05 | 5 | 203 | 3 | PF02140 | |
| Domain | GPCR_2_latrophilin | 1.25e-05 | 5 | 203 | 3 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 1.25e-05 | 5 | 203 | 3 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.25e-05 | 5 | 203 | 3 | PS50228 | |
| Domain | - | PPP2R2D FSTL5 FSTL4 LYST CORO2B SEMA6D TULP4 NBEAL2 DCAF4L2 MST1R NBAS PPP2R2C DCAF10 WDR11 | 1.77e-05 | 333 | 203 | 14 | 2.130.10.10 |
| Domain | FN3_dom | PRTG COL6A3 FLNC COL7A1 KALRN L1CAM EPHA2 RIMBP2 PRLR EPHA3 EPHA5 | 1.87e-05 | 209 | 203 | 11 | IPR003961 |
| Domain | WD40/YVTN_repeat-like_dom | PPP2R2D FSTL5 FSTL4 LYST CORO2B SEMA6D TULP4 NBEAL2 DCAF4L2 MST1R NBAS PPP2R2C DCAF10 WDR11 | 1.89e-05 | 335 | 203 | 14 | IPR015943 |
| Domain | ANK | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTED POTEC POTEM POTEJ POTEI | 2.03e-05 | 251 | 203 | 12 | SM00248 |
| Domain | ANK_REPEAT | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTED POTEC POTEM POTEJ POTEI | 2.20e-05 | 253 | 203 | 12 | PS50088 |
| Domain | Actin_CS | 2.23e-05 | 16 | 203 | 4 | IPR004001 | |
| Domain | ANK_REP_REGION | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTED POTEC POTEM POTEJ POTEI | 2.29e-05 | 254 | 203 | 12 | PS50297 |
| Domain | Ank_2 | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTEC POTEM POTEJ POTEI | 2.43e-05 | 215 | 203 | 11 | PF12796 |
| Domain | WxxW_domain | 2.47e-05 | 6 | 203 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.47e-05 | 6 | 203 | 3 | PF13330 | |
| Domain | ACTINS_2 | 2.89e-05 | 17 | 203 | 4 | PS00432 | |
| Domain | Ankyrin_rpt | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTED POTEC POTEM POTEJ POTEI | 3.10e-05 | 262 | 203 | 12 | IPR002110 |
| Domain | Actin/actin-like_CS | 3.68e-05 | 18 | 203 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 4.62e-05 | 19 | 203 | 4 | PS01132 | |
| Domain | FN3 | PRTG COL6A3 COL7A1 KALRN L1CAM EPHA2 RIMBP2 PRLR EPHA3 EPHA5 | 6.63e-05 | 199 | 203 | 10 | PS50853 |
| Domain | fn3 | 7.15e-05 | 162 | 203 | 9 | PF00041 | |
| Domain | - | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTEC POTEM POTEJ POTEI | 8.86e-05 | 248 | 203 | 11 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 POTEF POTEG POTEC POTEM POTEJ POTEI | 1.10e-04 | 254 | 203 | 11 | IPR020683 |
| Domain | GAIN_dom_N | 1.96e-04 | 11 | 203 | 3 | IPR032471 | |
| Domain | GAIN | 1.96e-04 | 11 | 203 | 3 | PF16489 | |
| Domain | VWFA | 2.70e-04 | 82 | 203 | 6 | PS50234 | |
| Domain | VWA | 3.08e-04 | 84 | 203 | 6 | SM00327 | |
| Domain | Actin | 3.39e-04 | 31 | 203 | 4 | IPR004000 | |
| Domain | Actin | 3.39e-04 | 31 | 203 | 4 | PF00022 | |
| Domain | ACTIN | 3.39e-04 | 31 | 203 | 4 | SM00268 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.22e-04 | 14 | 203 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.22e-04 | 14 | 203 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.22e-04 | 14 | 203 | 3 | IPR001426 | |
| Domain | EphA2_TM | 4.22e-04 | 14 | 203 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.22e-04 | 14 | 203 | 3 | IPR001090 | |
| Domain | Eph_TM | 4.22e-04 | 14 | 203 | 3 | IPR027936 | |
| Domain | EPH_lbd | 4.22e-04 | 14 | 203 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 4.22e-04 | 14 | 203 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.22e-04 | 14 | 203 | 3 | IPR016257 | |
| Domain | EPH_LBD | 4.22e-04 | 14 | 203 | 3 | PS51550 | |
| Domain | GPS | 6.08e-04 | 36 | 203 | 4 | PS50221 | |
| Domain | GPS | 6.76e-04 | 37 | 203 | 4 | IPR000203 | |
| Domain | Tox-GHH_dom | 6.95e-04 | 4 | 203 | 2 | IPR028916 | |
| Domain | PP2A_PR55_CS | 6.95e-04 | 4 | 203 | 2 | IPR018067 | |
| Domain | Tox-GHH | 6.95e-04 | 4 | 203 | 2 | PF15636 | |
| Domain | PP2A_PR55 | 6.95e-04 | 4 | 203 | 2 | IPR000009 | |
| Domain | Ten_N | 6.95e-04 | 4 | 203 | 2 | IPR009471 | |
| Domain | Ten_N | 6.95e-04 | 4 | 203 | 2 | PF06484 | |
| Domain | TENEURIN_N | 6.95e-04 | 4 | 203 | 2 | PS51361 | |
| Domain | PR55_2 | 6.95e-04 | 4 | 203 | 2 | PS01025 | |
| Domain | PR55_1 | 6.95e-04 | 4 | 203 | 2 | PS01024 | |
| Domain | VWF_A | 7.42e-04 | 99 | 203 | 6 | IPR002035 | |
| Domain | CarboxyPept-like_regulatory | 7.69e-04 | 17 | 203 | 3 | IPR008969 | |
| Domain | Protein_kinase_ATP_BS | TNIK STK17B ITK NEK5 EIF2AK3 KALRN MINK1 MST1R EPHA2 PRKAA2 EPHA3 EPHA5 | 9.36e-04 | 379 | 203 | 12 | IPR017441 |
| Domain | WD_REPEATS_1 | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 NBAS PPP2R2C DCAF10 WDR11 | 9.59e-04 | 278 | 203 | 10 | PS00678 |
| Domain | Ig_E-set | 9.60e-04 | 104 | 203 | 6 | IPR014756 | |
| Domain | WD_REPEATS_2 | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 NBAS PPP2R2C DCAF10 WDR11 | 9.85e-04 | 279 | 203 | 10 | PS50082 |
| Domain | WD_REPEATS_REGION | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 NBAS PPP2R2C DCAF10 WDR11 | 9.85e-04 | 279 | 203 | 10 | PS50294 |
| Domain | Ig_I-set | 1.14e-03 | 190 | 203 | 8 | IPR013098 | |
| Domain | I-set | 1.14e-03 | 190 | 203 | 8 | PF07679 | |
| Domain | TF_AP2 | 1.15e-03 | 5 | 203 | 2 | IPR004979 | |
| Domain | TF_AP2_C | 1.15e-03 | 5 | 203 | 2 | IPR013854 | |
| Domain | YD | 1.15e-03 | 5 | 203 | 2 | IPR006530 | |
| Domain | TF_AP-2 | 1.15e-03 | 5 | 203 | 2 | PF03299 | |
| Domain | - | 1.19e-03 | 73 | 203 | 5 | 2.60.120.260 | |
| Domain | LamG | 1.31e-03 | 44 | 203 | 4 | SM00282 | |
| Domain | WD40_repeat_dom | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 PPP2R2C TENM3 DCAF10 WDR11 | 1.57e-03 | 297 | 203 | 10 | IPR017986 |
| Domain | PROTEIN_KINASE_ATP | TNIK STK17B NEK9 ITK NEK5 EIF2AK3 KALRN MINK1 MST1R EPHA2 PRKAA2 EPHA3 EPHA5 | 1.59e-03 | 459 | 203 | 13 | PS00107 |
| Domain | Quino_amine_DH_bsu | 1.67e-03 | 22 | 203 | 3 | IPR011044 | |
| Domain | PH_BEACH | 1.71e-03 | 6 | 203 | 2 | PF14844 | |
| Domain | 3Beta_HSD | 1.71e-03 | 6 | 203 | 2 | PF01073 | |
| Domain | 3Beta_OHSteriod_DH/Estase | 1.71e-03 | 6 | 203 | 2 | IPR002225 | |
| Domain | ACTININ_2 | 1.91e-03 | 23 | 203 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.91e-03 | 23 | 203 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.91e-03 | 23 | 203 | 3 | IPR001589 | |
| Domain | WD40 | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 PPP2R2C DCAF10 WDR11 | 2.16e-03 | 259 | 203 | 9 | PF00400 |
| Domain | Ephrin_rec_like | 2.44e-03 | 25 | 203 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.44e-03 | 25 | 203 | 3 | IPR011641 | |
| Domain | HormR | 2.44e-03 | 25 | 203 | 3 | SM00008 | |
| Domain | Kinase-like_dom | TNIK STK17B NEK9 ITK NEK5 EIF2AK3 KALRN MINK1 ACAD10 MST1R EPHA2 PRKAA2 EPHA3 EPHA5 | 2.49e-03 | 542 | 203 | 14 | IPR011009 |
| Domain | WD40 | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 PPP2R2C DCAF10 WDR11 | 2.72e-03 | 268 | 203 | 9 | SM00320 |
| Domain | Tyr_kinase_cat_dom | 2.73e-03 | 88 | 203 | 5 | IPR020635 | |
| Domain | TyrKc | 2.73e-03 | 88 | 203 | 5 | SM00219 | |
| Domain | Prot_kinase_dom | TNIK STK17B NEK9 ITK NEK5 EIF2AK3 KALRN MINK1 MST1R EPHA2 PRKAA2 EPHA3 EPHA5 | 2.76e-03 | 489 | 203 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TNIK STK17B NEK9 ITK NEK5 EIF2AK3 KALRN MINK1 MST1R EPHA2 PRKAA2 EPHA3 EPHA5 | 2.96e-03 | 493 | 203 | 13 | PS50011 |
| Domain | WD40_repeat | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 PPP2R2C DCAF10 WDR11 | 3.00e-03 | 272 | 203 | 9 | IPR001680 |
| Domain | PIWI | 3.15e-03 | 8 | 203 | 2 | PS50822 | |
| Domain | Piwi | 3.15e-03 | 8 | 203 | 2 | SM00950 | |
| Domain | DHC_N1 | 3.15e-03 | 8 | 203 | 2 | PF08385 | |
| Domain | Piwi | 3.15e-03 | 8 | 203 | 2 | PF02171 | |
| Domain | PH-BEACH_dom | 3.15e-03 | 8 | 203 | 2 | IPR023362 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.10e-10 | 15 | 209 | 6 | 16824795 | |
| Pubmed | 9.23e-10 | 9 | 209 | 5 | 16364570 | ||
| Pubmed | 1.84e-09 | 10 | 209 | 5 | 38713721 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 MYO10 PEX6 PTCH1 LYST NSD3 PLEKHG1 FASN FAT1 TULP4 NFATC1 NBEAL2 MAD1L1 DLX2 HECTD1 DYNC1H1 FLNA FLNC KALRN L1CAM RAPGEF1 ADGRL1 CDC14B MST1R ADAMTS7 CSPG4 | 3.42e-09 | 1105 | 209 | 26 | 35748872 |
| Pubmed | TNIK PALD1 MYO10 FSTL5 TSC1 ZEB2 PLEKHG1 FAF2 SEMA6D LRRC7 DYNC1H1 ADGRL3 ADGRL1 OPA1 TENM3 RIMBP2 | 4.16e-09 | 407 | 209 | 16 | 12693553 | |
| Pubmed | HEXB TNIK CDKAL1 SEMA6D VPS33B PIK3R1 ADGRL2 VAT1 MINK1 ADGRL1 OPA1 LRPPRC TENM3 EPHA2 EPHA3 | 4.71e-08 | 421 | 209 | 15 | 36976175 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HEXB CEACAM8 ITGAM POTEE FASN CILP2 SARS1 CPQ CPNE3 DNASE1 DYNC1H1 VAT1 FLNA COL6A3 COL15A1 CILP POTEF GPRC5A CUBN SLC12A3 CSPG4 POTEJ POTEI | 1.48e-07 | 1070 | 209 | 23 | 23533145 |
| Pubmed | alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins. | 2.14e-07 | 3 | 209 | 3 | 11520923 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 10994649 | ||
| Pubmed | The multiple actions of black widow spider toxins and their selective use in neurosecretion studies. | 2.14e-07 | 3 | 209 | 3 | 15066411 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 2.14e-07 | 3 | 209 | 3 | 17101985 | |
| Pubmed | PEX6 TSC1 LYST CDKAL1 FAF2 VPS33B WASHC5 PIK3R1 VPS13A ADGRL2 EIF2AK3 NBAS EPHA2 PRKAA2 TENM1 | 4.72e-07 | 504 | 209 | 15 | 34432599 | |
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 11773066 | ||
| Pubmed | 8.52e-07 | 4 | 209 | 3 | 16267007 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KCNH8 TSHZ2 NEK9 HNRNPL HOXC4 SHC2 TULP4 NFATC1 PTPRN2 NFIX MAD1L1 LRRC7 HECTD1 MINK1 ADGRL1 TECTA CDC14B MSRA CCNG2 LRPPRC PPP2R2C WDR11 PRKAA2 ABLIM2 PBX2 EPB41 | 1.17e-06 | 1489 | 209 | 26 | 28611215 |
| Pubmed | HEXB MAP1A TSC1 FASN CORO2B NF1 SARS1 WASHC5 NMT2 SYN1 LRRC7 METAP2 DYNC1H1 FLNA FLNC KALRN MINK1 L1CAM ADGRL1 OPA1 LRPPRC PPP2R2C SF3B1 RIMBP2 ABLIM2 | 1.89e-06 | 1431 | 209 | 25 | 37142655 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK TSC1 FAT1 NF1 CASKIN2 NBEAL2 VAT1 MINK1 RAPGEF1 GPRC5A EPHA2 CSPG4 DCBLD2 EPB41 EPHA3 | 2.12e-06 | 569 | 209 | 15 | 30639242 |
| Pubmed | Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease. | 3.63e-06 | 18 | 209 | 4 | 24058526 | |
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 17171436 | ||
| Pubmed | 4.22e-06 | 6 | 209 | 3 | 10964907 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 4.53e-06 | 71 | 209 | 6 | 28319113 | |
| Pubmed | 6.96e-06 | 163 | 209 | 8 | 24316575 | ||
| Pubmed | STARD13 TSC1 LYST ZEB2 POTEE FASN VPS13A CCDC191 PLS1 VAT1 FLNA FLNC MYH7B PCDHGA7 PCDHGA6 POTEF C2orf78 LRPPRC SF3B1 PHF20L1 CSPG4 TENM1 POTEJ POTEI | 6.97e-06 | 1442 | 209 | 24 | 35575683 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | SIDT1 BTBD1 LYST HNRNPL FAT1 VPS13A COL7A1 KALRN PCDHGA7 POTEG ZIC1 SF3B1 TENM1 ABLIM2 | 7.24e-06 | 552 | 209 | 14 | 10737800 |
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 15276201 | ||
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 7.36e-06 | 7 | 209 | 3 | 25816751 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PPP2R2D EXT2 CDKAL1 HNRNPL FASN FAF2 PTPRN2 CPNE3 ASCC3 ADGRL2 HECTD1 PLS1 FLNA FLNC PREPL OPA1 LRPPRC EPHA2 PRKAA2 | 7.64e-06 | 974 | 209 | 19 | 28675297 |
| Pubmed | MAP1A SS18 NSD3 KIAA1549L PIK3R1 FLNA FLNC LAMA4 RAPGEF1 ADGRL1 SF3B1 ARID2 ABLIM2 | 8.80e-06 | 486 | 209 | 13 | 20936779 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 1.03e-05 | 23 | 209 | 4 | 25480914 | |
| Pubmed | 1.17e-05 | 8 | 209 | 3 | 12475935 | ||
| Pubmed | A model for the molecular underpinnings of tooth defects in Axenfeld-Rieger syndrome. | 1.17e-05 | 8 | 209 | 3 | 23975681 | |
| Pubmed | 1.17e-05 | 8 | 209 | 3 | 31638440 | ||
| Pubmed | Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development. | 1.23e-05 | 24 | 209 | 4 | 29878134 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | PTCH1 SEMA6D DLX2 DYNC1H1 HDAC6 OPA1 ZIC2 MSRA SF3B1 TENM3 EPHA3 | 1.23e-05 | 358 | 209 | 11 | 32460013 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXB FSTL4 EXT2 NEK9 CDKAL1 OLFML2A FAT1 NF1 HECTD1 EIF2AK3 CA12 COL7A1 COL15A1 L1CAM LAMA4 GPRC5A MST1R TENM3 EPHA2 CSPG4 DCBLD2 | 1.31e-05 | 1201 | 209 | 21 | 35696571 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.38e-05 | 235 | 209 | 9 | 30258100 | |
| Pubmed | SIDT1 HNRNPL POTEE ACAN HECTD1 EIF2AK3 COL6A3 POTEF TECTA MSRA ENAM SF3B1 TENM1 | 1.56e-05 | 513 | 209 | 13 | 25798074 | |
| Pubmed | 1.75e-05 | 9 | 209 | 3 | 11403717 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PPP2R2D ZEB2 HNRNPL FASN NFATC1 NFIX MAD1L1 ADGRL2 EIF2AK3 DYNC1H1 FLNC HDAC6 RFX3 ZIC2 SF3B1 PHF20L1 PBX2 | 1.89e-05 | 857 | 209 | 17 | 25609649 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | STARD13 TNIK MYO10 CDH23 NEK9 C3orf20 CDKAL1 PLEKHG1 NF1 VPS33B NBEAL2 VPS13A SLAMF9 MYH7B ARRDC5 LRPPRC ABHD5 ARID2 RIMBP2 DCBLD2 LRRC23 | 2.15e-05 | 1242 | 209 | 21 | 30973865 |
| Pubmed | 2.32e-05 | 251 | 209 | 9 | 29031500 | ||
| Pubmed | 2.32e-05 | 28 | 209 | 4 | 21820362 | ||
| Pubmed | TNIK TSC1 NEK9 ZEB2 NF1 PTPRN2 MAD1L1 SYN1 LRRC7 DYNC1H1 KALRN MINK1 PREPL OPA1 ZIC2 LRPPRC SF3B1 RIMBP2 | 2.35e-05 | 963 | 209 | 18 | 28671696 | |
| Pubmed | 2.49e-05 | 10 | 209 | 3 | 25073978 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 2.49e-05 | 10 | 209 | 3 | 16547242 | |
| Pubmed | Disruption of FAT10-MAD2 binding inhibits tumor progression. | 2.49e-05 | 10 | 209 | 3 | 25422469 | |
| Pubmed | PALD1 CDKAL1 FASN LRRC7 ASCC3 ADGRL2 EIF2AK3 DYNC1H1 HDAC6 MINK1 OPA1 LRPPRC EPHA2 EPB41 EPHA3 | 2.81e-05 | 708 | 209 | 15 | 39231216 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | OVOL2 SP8 HOXC4 HOXC9 NFATC1 NFIX DLX2 DMRT1 SOX30 RFX3 TFAP2B TFAP2C ZIC1 | 2.86e-05 | 544 | 209 | 13 | 28473536 |
| Pubmed | 2.87e-05 | 59 | 209 | 5 | 32382008 | ||
| Pubmed | Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice. | 3.41e-05 | 11 | 209 | 3 | 24550361 | |
| Pubmed | 3.41e-05 | 11 | 209 | 3 | 26269506 | ||
| Pubmed | 3.41e-05 | 11 | 209 | 3 | 15517401 | ||
| Pubmed | Zic2 controls cerebellar development in cooperation with Zic1. | 3.41e-05 | 11 | 209 | 3 | 11756505 | |
| Pubmed | 3.49e-05 | 149 | 209 | 7 | 22664934 | ||
| Pubmed | 3.51e-05 | 31 | 209 | 4 | 36362374 | ||
| Pubmed | Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. | 3.59e-05 | 2 | 209 | 2 | 14665668 | |
| Pubmed | A new allelic series for the underwhite gene on mouse chromosome 15. | 3.59e-05 | 2 | 209 | 2 | 9864865 | |
| Pubmed | Latrophilin receptors: novel bronchodilator targets in asthma. | 3.59e-05 | 2 | 209 | 2 | 27325752 | |
| Pubmed | The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway. | 3.59e-05 | 2 | 209 | 2 | 21502810 | |
| Pubmed | Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter. | 3.59e-05 | 2 | 209 | 2 | 11038359 | |
| Pubmed | Zic-Proteins Are Repressors of Dopaminergic Forebrain Fate in Mice and C. elegans. | 3.59e-05 | 2 | 209 | 2 | 28972122 | |
| Pubmed | Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein. | 3.59e-05 | 2 | 209 | 2 | 18547142 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 9029734 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 9029733 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 2243100 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 3.59e-05 | 2 | 209 | 2 | 19669888 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 12205101 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 12810687 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 24075909 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 20504929 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 28425622 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 33646123 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 10679933 | ||
| Pubmed | High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians. | 3.59e-05 | 2 | 209 | 2 | 37274334 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 1924345 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 16478974 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 3.59e-05 | 2 | 209 | 2 | 24469451 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 21677667 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 33664869 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 20980607 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 32203162 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 21232086 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 11133676 | ||
| Pubmed | Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. | 3.59e-05 | 2 | 209 | 2 | 18762778 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 11912155 | ||
| Pubmed | Association of the variations in the HSD3β gene with primary aldosteronism. | 3.59e-05 | 2 | 209 | 2 | 24006038 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 1944309 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 7491113 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 10103023 | ||
| Pubmed | Regulation of chromatin accessibility and Zic binding at enhancers in the developing cerebellum. | 3.59e-05 | 2 | 209 | 2 | 25849986 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 17689071 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 33997712 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 19923902 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 30635602 | ||
| Pubmed | Chaperones rejuvenate folding and activity of 3-β hydroxysteroid dehydrogenase 2. | 3.59e-05 | 2 | 209 | 2 | 23485106 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 23583712 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 18524572 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 19414525 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 18778748 | ||
| Pubmed | 3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. | 3.59e-05 | 2 | 209 | 2 | 25458695 | |
| Cytoband | 2q21.1 | 1.46e-04 | 58 | 209 | 4 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.39e-14 | 13 | 141 | 8 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | POTEE CASKIN2 ASB6 ANKRD18A HECTD1 ANKRD30BL POTEF POTEG POTED POTEC POTEM POTEJ POTEI | 5.57e-08 | 242 | 141 | 13 | 403 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 1.85e-06 | 4 | 141 | 3 | 918 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.59e-04 | 14 | 141 | 3 | 1095 | |
| GeneFamily | WD repeat domain containing | PPP2R2D LYST CORO2B TULP4 NBEAL2 DCAF4L2 PPP2R2C DCAF10 WDR11 | 2.18e-04 | 262 | 141 | 9 | 362 |
| GeneFamily | Fibronectin type III domain containing | 2.61e-04 | 160 | 141 | 7 | 555 | |
| GeneFamily | Argonaute/PIWI family | 1.64e-03 | 8 | 141 | 2 | 408 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.10e-03 | 9 | 141 | 2 | 1230 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KCNH8 TSHZ2 ANO5 LYST NDST3 UBXN2B KIAA1549L SEMA6D CSRNP3 TULP4 PRSS53 NFIX ANKRD18A LRRC7 ADGRL3 L1CAM ADGRL1 PREPL SLC7A14 CEMIP PPP2R2C PRKAA2 TENM1 RIMBP2 PRLR EPB41 EPHA3 | 2.26e-07 | 1106 | 208 | 27 | M39071 |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | MYO10 OLFML2A CPQ SULF1 PIK3R1 ACAN IL33 FLNC COL15A1 CILP GPRC5A CEMIP TENM3 TENM1 EPHA3 | 1.83e-06 | 427 | 208 | 15 | M17923 |
| Coexpression | NABA_CORE_MATRISOME | MFAP2 CILP2 INTS14 ACAN AMELY COL6A3 COL7A1 COL15A1 CILP LAMA4 TECTA | 1.14e-05 | 270 | 208 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | MFAP2 CILP2 INTS14 ACAN AMELY COL6A3 COL7A1 COL15A1 CILP LAMA4 TECTA | 1.35e-05 | 275 | 208 | 11 | M5884 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | TSHZ2 TSC1 UBXN2B KIAA1549L SEMA6D CSRNP3 TULP4 PIK3R1 LRRC7 VAT1 KALRN L1CAM ENPP4 TENM1 EPB41 EPHA5 | 1.90e-05 | 584 | 208 | 16 | M39068 |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 2.97e-05 | 197 | 208 | 9 | M8983 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.39e-05 | 147 | 206 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.61e-05 | 207 | 206 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_100 | 4.48e-05 | 97 | 206 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MAP1A TSHZ2 PTCH1 ZEB2 MFAP2 HOXC4 SEMA6D CSRNP3 SULF1 PIK3R1 ADGRL2 ADGRL3 FLNA COL6A3 FLNC KALRN ZNF569 RUNX1 CCNG2 TENM3 DCBLD2 | 5.81e-05 | 827 | 206 | 21 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | TSHZ2 ZEB2 MFAP2 HOXC4 PIK3R1 NFIX FLNA COL6A3 FLNC TENM3 EPHA3 | 5.91e-05 | 265 | 206 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | MAP1A TSHZ2 ZEB2 MFAP2 HOXC4 SULF1 ADGRL2 ADGRL3 FLNA COL6A3 FLNC KALRN RUNX1 TENM3 | 6.22e-05 | 418 | 206 | 14 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | TNIK ZEB2 PLEKHG1 SP8 CSRNP3 NFATC1 SULF1 NFIX VPS13A DLX2 ADGRL3 COL7A1 LAMA4 RUNX1 CDC14B TFAP2B TFAP2C TENM1 DCBLD2 EPHA5 | 6.33e-05 | 769 | 206 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | TNIK TSHZ2 ZEB2 MFAP2 HOXC4 SEMA6D SULF1 PIK3R1 NFIX NMT2 ADGRL2 ADGRL3 FLNA COL6A3 FLNC RUNX1 CDC14B TENM3 EPHA3 | 1.15e-04 | 740 | 206 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | MAP1A TSHZ2 ZEB2 MFAP2 HOXC4 PIK3R1 FLNA COL6A3 FLNC KALRN ZNF569 TENM3 | 1.18e-04 | 337 | 206 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TNIK TSHZ2 MYO10 ZC3H12B PTCH1 ZEB2 MFAP2 FAT1 SULF1 HSD3B2 ADGRL2 ADGRL3 FLNA COL6A3 FLNC CDC14B TENM3 PRLR EPHA3 | 1.85e-04 | 768 | 206 | 19 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.91e-04 | 122 | 206 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500 | 1.91e-04 | 86 | 206 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | TSHZ2 MFAP2 SEMA6D SULF1 PIK3R1 ADGRL2 ADGRL3 COL6A3 FLNC RUNX1 TENM3 EPHA3 | 2.02e-04 | 357 | 206 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | TSHZ2 PTCH1 ZEB2 MFAP2 SULF1 HSD3B2 ADGRL3 COL6A3 FLNC TENM3 PRLR EPHA3 | 2.24e-04 | 361 | 206 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | TSHZ2 PTCH1 ZEB2 FAT1 SULF1 HSD3B2 ADGRL3 FLNA COL6A3 FLNC CDC14B PRLR | 2.41e-04 | 364 | 206 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | TNIK SIDT1 PPM1J ITGAM ZEB2 ITK UBXN2B NBEAL2 CDC14B CD6 PHF20L1 LY9 | 2.73e-04 | 369 | 206 | 12 | GSM605891_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TNIK MAP1A TSHZ2 MYO10 ZC3H12B PTCH1 ZEB2 MFAP2 FAT1 SULF1 HSD3B2 ADGRL3 FLNA COL6A3 FLNC CDC14B TENM3 PRLR EPHA3 | 2.77e-04 | 793 | 206 | 19 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 2.80e-04 | 217 | 206 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | STARD13 TNIK PRTG TBRG4 NFIX ADGRL3 CA12 COL6A3 COL7A1 RUNX1 TFAP2B ZIC2 EPHA3 EPHA5 | 2.98e-04 | 486 | 206 | 14 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | PRTG KIAA1549L NFIX HSD3B1 ADGRL3 COL6A3 COL7A1 RUNX1 TFAP2B ZIC1 ZIC2 CSPG4 EPHA3 EPHA5 | 3.17e-04 | 489 | 206 | 14 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PTCH1 MFAP2 FAT1 KIAA1549L SEMA6D COL6A3 COL7A1 COL15A1 ITGA10 LAMA4 CEMIP CSPG4 EPHA3 | 3.26e-12 | 179 | 209 | 13 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PTCH1 OLFML2A FAT1 HOXC9 KIAA1549L SULF1 COL6A3 COL15A1 ITGA10 LAMA4 CEMIP CSPG4 | 1.76e-10 | 197 | 209 | 12 | c165c6fd12dc649b39e920d8528e2eb65c61956b |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PPM1J OVOL2 FAT1 DNASE1 CA12 COL7A1 TCN1 DOK7 CEMIP NPHP3 WDR11 | 1.18e-09 | 183 | 209 | 11 | bbf27d2f4369031fadacacd6c432c06b1ec5abdb |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PTCH1 MFAP2 FAT1 HOXC9 KIAA1549L COL6A3 COL15A1 PCDHGA6 ITGA10 LAMA4 CEMIP | 1.57e-09 | 188 | 209 | 11 | ed92cddf47defea2f904d36c7ae05ffa323349a9 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 SULF1 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 TENM3 EPHA3 | 3.10e-08 | 195 | 209 | 10 | dd281a249854800f737dc22e0f375f66dfb5cf5f |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 ZEB2 SULF1 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 TENM3 | 3.10e-08 | 195 | 209 | 10 | edd4cd8402af81737b2074f9dce71cc6ab09be7e |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 SULF1 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 TENM3 EPHA3 | 3.10e-08 | 195 | 209 | 10 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ZEB2 SULF1 ACAN LRRC7 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 | 3.25e-08 | 196 | 209 | 10 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ZEB2 SULF1 ACAN LRRC7 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 | 3.25e-08 | 196 | 209 | 10 | 1c8294014713684b50885e638668f2ce75f357f0 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 ZEB2 SULF1 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 TENM3 | 3.25e-08 | 196 | 209 | 10 | fa445f4240c521cf04eb2e2f79a5c55fda31209a |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 ZEB2 SULF1 ADGRL3 FLNA COL6A3 COL15A1 KALRN LAMA4 TENM3 | 3.25e-08 | 196 | 209 | 10 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 PTCH1 ZEB2 SULF1 COL6A3 COL15A1 KALRN LAMA4 CEMIP TENM3 | 3.41e-08 | 197 | 209 | 10 | ae0435f4b4a9cdedb1c201fc56921048390097bf |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 PTCH1 ZEB2 SULF1 COL6A3 COL15A1 KALRN LAMA4 CEMIP TENM3 | 3.41e-08 | 197 | 209 | 10 | 37f6b6f2809b952382eaebb642b0aad6371f4251 |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TSHZ2 PTCH1 OLFML2A MFAP2 HOXC9 SULF1 ADGRL3 COL6A3 ITGA10 LAMA4 | 3.58e-08 | 198 | 209 | 10 | d83707b69fb64721ac3cff90ba58cdd999d6b386 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | KIAA1549L CSRNP3 PTPRN2 LRRC7 ADGRL2 ANKRD30BL KALRN PREPL RIMBP2 ABLIM2 | 3.93e-08 | 200 | 209 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PTCH1 OLFML2A MFAP2 FAT1 KIAA1549L SULF1 COL6A3 LAMA4 CSPG4 EPHA3 | 3.93e-08 | 200 | 209 | 10 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-08 | 200 | 209 | 10 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.75e-08 | 162 | 209 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.55e-08 | 166 | 209 | 9 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.73e-07 | 178 | 209 | 9 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | STARD13 PALD1 FSTL4 PLEKHG1 CASKIN2 ADGRL2 ADGRL3 KALRN ITGA10 | 1.91e-07 | 180 | 209 | 9 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-07 | 182 | 209 | 9 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 184 | 209 | 9 | 42cadfdb5d29a50bd7e901ddd14d42b39e8474f0 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.30e-07 | 184 | 209 | 9 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-07 | 185 | 209 | 9 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | TSHZ2 COLGALT2 CORO2B SULF1 ADGRL3 COL6A3 COL15A1 CILP EPHA3 | 2.40e-07 | 185 | 209 | 9 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.88e-07 | 189 | 209 | 9 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-07 | 189 | 209 | 9 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | STARD13 PALD1 FSTL4 PLEKHG1 CASKIN2 ADGRL2 ADGRL3 KALRN ITGA10 | 2.88e-07 | 189 | 209 | 9 | b6b4da51bc7f2c13a2f940540fdc61027d084835 |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.88e-07 | 189 | 209 | 9 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-07 | 190 | 209 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-07 | 191 | 209 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.15e-07 | 191 | 209 | 9 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-07 | 191 | 209 | 9 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.15e-07 | 191 | 209 | 9 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-07 | 191 | 209 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-07 | 192 | 209 | 9 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 3.29e-07 | 192 | 209 | 9 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-07 | 193 | 209 | 9 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-07 | 193 | 209 | 9 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-07 | 194 | 209 | 9 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-07 | 194 | 209 | 9 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 195 | 209 | 9 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-07 | 195 | 209 | 9 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | FSTL4 KIAA1549L CSRNP3 PIK3R1 VPS13A LRRC7 KALRN MSRA PPP2R2C | 3.75e-07 | 195 | 209 | 9 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO10 TULP4 PRSS53 PTPRN2 VPS13A ASCC3 DYNC1H1 HDAC6 SLC7A14 | 3.75e-07 | 195 | 209 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.75e-07 | 195 | 209 | 9 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 3.91e-07 | 196 | 209 | 9 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.08e-07 | 197 | 209 | 9 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-07 | 197 | 209 | 9 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-07 | 197 | 209 | 9 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 4.08e-07 | 197 | 209 | 9 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.08e-07 | 197 | 209 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.26e-07 | 198 | 209 | 9 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | KIAA1549L CSRNP3 PTPRN2 LRRC7 ADGRL2 ANKRD30BL KALRN PREPL RIMBP2 | 4.26e-07 | 198 | 209 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.44e-07 | 199 | 209 | 9 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-07 | 199 | 209 | 9 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-07 | 200 | 209 | 9 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.63e-07 | 200 | 209 | 9 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.63e-07 | 200 | 209 | 9 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-07 | 200 | 209 | 9 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-07 | 200 | 209 | 9 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.63e-07 | 200 | 209 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.63e-07 | 200 | 209 | 9 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 4.63e-07 | 200 | 209 | 9 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-07 | 200 | 209 | 9 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.10e-07 | 63 | 209 | 6 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.22e-06 | 166 | 209 | 8 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 166 | 209 | 8 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-06 | 166 | 209 | 8 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-06 | 169 | 209 | 8 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.52e-06 | 171 | 209 | 8 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-06 | 171 | 209 | 8 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-06 | 172 | 209 | 8 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.66e-06 | 173 | 209 | 8 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.66e-06 | 173 | 209 | 8 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-06 | 174 | 209 | 8 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-06 | 174 | 209 | 8 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-06 | 174 | 209 | 8 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.74e-06 | 174 | 209 | 8 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-06 | 175 | 209 | 8 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-06 | 175 | 209 | 8 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 176 | 209 | 8 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 176 | 209 | 8 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-06 | 176 | 209 | 8 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.23e-06 | 180 | 209 | 8 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-06 | 182 | 209 | 8 | 9fc2f84bf70ad9a11c8a7326bd101e6f6cbcc33e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 182 | 209 | 8 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-06 | 182 | 209 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 182 | 209 | 8 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-06 | 183 | 209 | 8 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 2.63e-06 | 184 | 209 | 8 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 2.63e-06 | 184 | 209 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.74e-06 | 185 | 209 | 8 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.74e-06 | 185 | 209 | 8 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 186 | 209 | 8 | 2fab7abed16a894afdd0207e86fc43a25a77fb9e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 186 | 209 | 8 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.85e-06 | 186 | 209 | 8 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 186 | 209 | 8 | 714765585a644bf9817ab6eb3001b43b3c2d2410 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 186 | 209 | 8 | ea2c8e0df038a00062d2098b4a9ac85141b9a728 | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; PC3; HT_HG-U133A | STK17B ITK NF1 PTPRN2 CASKIN2 NBEAL2 MINK1 LAMA4 ADGRL1 RUNX1 CDC14B FGF23 | 2.70e-07 | 197 | 207 | 12 | 5803_DN |
| Drug | C-cluster | MAP1A HOXC4 HOXC9 NF1 EIF2AK3 DYNC1H1 MINK1 ENAM WDR11 LRRC23 | 5.97e-07 | 139 | 207 | 10 | CID000446537 |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | TNIK PTCH1 HOXC4 NF1 VPS13A MINK1 LAMA4 RUNX1 TFAP2C CSPG4 PRLR | 2.12e-06 | 198 | 207 | 11 | 7380_UP |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.14e-05 | 193 | 207 | 10 | 2332_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | OLFML2A INTS14 NF1 NFIX ACAN VPS13A COL7A1 ADGRL1 ENPP4 LRRC23 | 1.31e-05 | 196 | 207 | 10 | 7502_UP |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.37e-05 | 197 | 207 | 10 | 6642_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 1.37e-05 | 197 | 207 | 10 | 6663_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 4195_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A | MAP1A FSTL4 HOXC4 CORO2B KALRN LAMA4 CD6 RIMBP2 DCBLD2 EPB41 | 1.43e-05 | 198 | 207 | 10 | 3033_UP |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 7500_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | TNIK MAP1A NFATC1 CASKIN2 NFIX NBEAL2 MAD1L1 MINK1 ADGRL1 RUNX1 | 1.43e-05 | 198 | 207 | 10 | 7366_DN |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 207 | 10 | 6460_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | TNIK STK17B OLFML2A NF1 PTPRN2 SOX30 MINK1 ADGRL1 ACAD10 CDC14B | 1.43e-05 | 198 | 207 | 10 | 7373_UP |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | MAP1A STK17B HOXC4 NF1 COL7A1 ADGRL1 RUNX1 CEMIP FGF23 EPHA3 | 1.49e-05 | 199 | 207 | 10 | 2744_UP |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | 1.49e-05 | 199 | 207 | 10 | 6882_DN | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.49e-05 | 199 | 207 | 10 | 4211_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A | 1.49e-05 | 199 | 207 | 10 | 2543_UP | |
| Drug | amitriptyline hydrochloride; Up 200; 1uM; MCF7; HG-U133A | STARD13 TBRG4 MAP1A COLGALT2 ITGAM SEMA6D NFATC1 TCN1 ADGRL1 SLC45A2 | 1.49e-05 | 199 | 207 | 10 | 167_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.99e-05 | 179 | 207 | 9 | 4184_UP | |
| Drug | 3,16-diene | 4.01e-05 | 8 | 207 | 3 | CID000101964 | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 4.17e-05 | 180 | 207 | 9 | 4776_UP | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 6.09e-05 | 189 | 207 | 9 | 2300_UP | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 6.34e-05 | 190 | 207 | 9 | 6253_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 6.60e-05 | 191 | 207 | 9 | 4279_DN | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 6.60e-05 | 191 | 207 | 9 | 2850_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 6.60e-05 | 191 | 207 | 9 | 3058_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; PC3; HT_HG-U133A | 6.60e-05 | 191 | 207 | 9 | 5085_DN | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 6.87e-05 | 192 | 207 | 9 | 1173_DN | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.15e-05 | 193 | 207 | 9 | 6485_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 7.15e-05 | 193 | 207 | 9 | 3708_UP | |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | SS18 KIAA1549L PTPRN2 CASKIN2 NFIX ITGA10 TFAP2C CCNG2 LRRC23 | 7.44e-05 | 194 | 207 | 9 | 6555_DN |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 4174_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 3807_DN | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 5104_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 1632_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 4467_UP | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 6662_DN | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 3564_UP | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 3534_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 3083_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 7128_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 5111_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 5088_UP | |
| Drug | 3-oxo-delta 5-steroid | 8.23e-05 | 2 | 207 | 2 | CID000439372 | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 2848_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 4433_UP | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 8.37e-05 | 197 | 207 | 9 | 255_UP | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 3554_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 4727_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 4613_DN | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 7360_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 6239_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 7293_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; PC3; HT_HG-U133A | MAP1A COLGALT2 OLFML2A NF1 PTPRN2 CASKIN2 NBEAL2 RUNX1 CEMIP | 8.70e-05 | 198 | 207 | 9 | 5737_DN |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 5110_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 3237_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 4491_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 4189_UP | |
| Drug | CGX 0596987; Up 200; 20uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 6369_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 4432_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 7310_DN | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 3329_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 3736_DN | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 7430_UP | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 3554_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 6505_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 2094_DN | |
| Drug | Methacholine chloride [62-51-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 5773_DN | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 4008_UP | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 6693_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 5540_UP | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 3546_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; HL60; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 2545_UP | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 4571_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 3927_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 167 | 207 | 8 | 6047_UP | |
| Drug | pyrachlostrobin | STARD13 HEXB MYO10 SIDT1 ITGAM FAT1 CPQ NFATC1 CASKIN2 SULF1 CPNE3 FLNA FLNC ACAD10 GPRC5A ZIC2 CEMIP EPHA2 CSPG4 | 1.63e-04 | 811 | 207 | 19 | ctd:C513428 |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.41e-04 | 179 | 207 | 8 | 4248_UP | |
| Drug | DFC-28 | 2.50e-04 | 14 | 207 | 3 | CID005743054 | |
| Drug | type-IV | 2.65e-04 | 281 | 207 | 10 | CID000000906 | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.70e-04 | 182 | 207 | 8 | 4376_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | 3.24e-04 | 187 | 207 | 8 | 4448_UP | |
| Drug | BIRB796 | 3.37e-04 | 66 | 207 | 5 | CID000156422 | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.61e-04 | 190 | 207 | 8 | 7546_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.73e-04 | 191 | 207 | 8 | 3830_UP | |
| Drug | cyclosporine A; Up 200; 1uM; MCF7; HG-U133A | 3.73e-04 | 191 | 207 | 8 | 261_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 3.73e-04 | 191 | 207 | 8 | 3803_DN | |
| Drug | 6'-sialyllactose | 3.80e-04 | 16 | 207 | 3 | CID000643987 | |
| Drug | O-C-O | 3.80e-04 | 104 | 207 | 6 | CID000014785 | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 3.87e-04 | 192 | 207 | 8 | 6050_UP | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.87e-04 | 192 | 207 | 8 | 4801_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 5998_UP | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 3562_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 4466_UP | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 7490_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 4.00e-04 | 193 | 207 | 8 | 4226_DN | |
| Drug | gold nanoparticles | 4.01e-04 | 243 | 207 | 9 | CID000023985 | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 7399_UP | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 2753_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 4.14e-04 | 194 | 207 | 8 | 1239_UP | |
| Disease | Colorectal Carcinoma | FSTL5 ZEB2 NDST3 FAT1 CORO2B HOXC9 NF1 CSRNP3 NFATC1 PTPRN2 VPS13A FLNC COL7A1 KALRN ZNF569 CUBN TENM1 EPHA3 | 1.28e-06 | 702 | 197 | 18 | C0009402 |
| Disease | Disproportionate short stature | 1.31e-05 | 77 | 197 | 6 | C0878659 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 3.48e-05 | 28 | 197 | 4 | DOID:1094 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | HEXB TNIK PALD1 PRTG STK17B SIDT1 PTCH1 CDKAL1 PLEKHG1 SP8 MFAP2 PIK3R1 NFIX ADGRL2 METAP2 PLS1 TFAP2B ZIC1 MSRA SF3B1 ADAMTS7 PRLR EPHA3 | 3.58e-05 | 1345 | 197 | 23 | EFO_0010736 |
| Disease | sleep disorder (implicated_via_orthology) | 4.65e-05 | 11 | 197 | 3 | DOID:535 (implicated_via_orthology) | |
| Disease | risk-taking behaviour | PRTG TSHZ2 CDH23 PTCH1 NF1 SEMA6D TULP4 PTPRN2 MAD1L1 ASCC3 METAP2 ADGRL3 MSRA LRPPRC ABHD5 EPHA5 | 5.96e-05 | 764 | 197 | 16 | EFO_0008579 |
| Disease | glomerular filtration rate, renal transplant outcome measurement | 8.58e-05 | 35 | 197 | 4 | EFO_0005199, EFO_0005208 | |
| Disease | cognitive function measurement | PPP2R2D FSTL4 PTCH1 SS18 PLEKHG1 SEMA6D ALMS1 TULP4 PTPRN2 NFIX MAD1L1 CPNE3 LRRC7 KALRN CDC14B TFAP2B CEMIP MST1R LRPPRC RIMBP2 ABLIM2 PRLR EPHA5 | 9.43e-05 | 1434 | 197 | 23 | EFO_0008354 |
| Disease | glycodeoxycholate measurement | 1.01e-04 | 14 | 197 | 3 | EFO_0010493 | |
| Disease | Drug habituation | 1.26e-04 | 115 | 197 | 6 | C0013170 | |
| Disease | Drug abuse | 1.26e-04 | 115 | 197 | 6 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.26e-04 | 115 | 197 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 1.26e-04 | 115 | 197 | 6 | C0236969 | |
| Disease | Drug Use Disorders | 1.26e-04 | 115 | 197 | 6 | C0013222 | |
| Disease | Drug Dependence | 1.26e-04 | 115 | 197 | 6 | C1510472 | |
| Disease | Substance Dependence | 1.26e-04 | 115 | 197 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 1.26e-04 | 115 | 197 | 6 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.26e-04 | 115 | 197 | 6 | C0029231 | |
| Disease | Substance abuse problem | 1.32e-04 | 116 | 197 | 6 | C0740858 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.32e-04 | 3 | 197 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.32e-04 | 3 | 197 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | sleep duration | TNIK CDH23 ENO4 SEMA6D CPQ MAD1L1 METAP2 MINK1 TMEM132E PIWIL3 | 1.73e-04 | 362 | 197 | 10 | EFO_0005271 |
| Disease | Gastric Adenocarcinoma | 2.32e-04 | 45 | 197 | 4 | C0278701 | |
| Disease | diet measurement | PPP2R2D SP8 NF1 UBXN2B SEMA6D PIK3R1 NFIX CDC16 MAD1L1 ADGRL2 RUNX1 RFX3 TFAP2B ZIC1 MSRA NBAS ABHD5 ARID2 | 2.52e-04 | 1049 | 197 | 18 | EFO_0008111 |
| Disease | systolic blood pressure, waist-hip ratio | 2.64e-04 | 4 | 197 | 2 | EFO_0004343, EFO_0006335 | |
| Disease | Liposarcoma, Pleomorphic | 2.64e-04 | 4 | 197 | 2 | C0205825 | |
| Disease | myopathy (implicated_via_orthology) | 2.98e-04 | 48 | 197 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | lymphocyte count | TNIK PALD1 HLA-DOA CDH23 LYST CILP2 ALMS1 NFATC1 PIK3R1 NFIX MED30 DNAH10 KALRN PCDHGA7 PCDHGA6 POTEF MINK1 ACAD10 MST1R CD6 PRKAA2 LY9 | 3.34e-04 | 1464 | 197 | 22 | EFO_0004587 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TSHZ2 CDH23 SEMA6D ALMS1 TULP4 PTPRN2 MAD1L1 ASCC3 ADGRL2 ADGRL3 MINK1 TFAP2B LRPPRC ABHD5 PHF20L1 | 3.38e-04 | 801 | 197 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | skin hydration measurement | 3.57e-04 | 21 | 197 | 3 | EFO_0009586 | |
| Disease | Arthrogryposis | 3.57e-04 | 21 | 197 | 3 | C0003886 | |
| Disease | nevus count, cutaneous melanoma | 3.68e-04 | 91 | 197 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | coronary artery disease | NEK9 ZEB2 PLEKHG1 SP8 VPS33B MAD1L1 LRRC7 ADGRL2 ADGRL3 VAT1 COL6A3 DNAH10 DOK7 ACAD10 TFAP2B ENAM ABHD5 ADAMTS7 PBX2 | 4.33e-04 | 1194 | 197 | 19 | EFO_0001645 |
| Disease | Anemia, Megaloblastic | 4.38e-04 | 5 | 197 | 2 | C0002888 | |
| Disease | muscular disease (implicated_via_orthology) | 4.38e-04 | 5 | 197 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Sarcosine measurement | 4.70e-04 | 23 | 197 | 3 | EFO_0021668 | |
| Disease | Alzheimer disease, APOE carrier status | 5.18e-04 | 98 | 197 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | response to peginterferon alfa-2a | 6.05e-04 | 25 | 197 | 3 | EFO_0010103 | |
| Disease | FEV/FEC ratio | STARD13 CDH23 PTCH1 ZEB2 MFAP2 HOXC4 NFATC1 SULF1 ACAN METAP2 IL33 COL6A3 COL15A1 SOX30 TFAP2C CCNG2 CSPG4 PBX2 LRRC23 | 6.08e-04 | 1228 | 197 | 19 | EFO_0004713 |
| Disease | myocardial infarction | 6.11e-04 | 350 | 197 | 9 | EFO_0000612 | |
| Disease | liposarcoma | 6.54e-04 | 6 | 197 | 2 | C0023827 | |
| Disease | Liposarcoma, well differentiated | 6.54e-04 | 6 | 197 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 6.54e-04 | 6 | 197 | 2 | C0205824 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 6.54e-04 | 6 | 197 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 8.18e-04 | 163 | 197 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | cortical thickness, neuroimaging measurement | 8.75e-04 | 110 | 197 | 5 | EFO_0004346, EFO_0004840 | |
| Disease | Prostatic Neoplasms | FAF2 PIK3R1 MAD1L1 CPNE3 HSD3B1 HSD3B2 COL15A1 HDAC6 RUNX1 ZIC2 SF3B1 ARID2 | 9.47e-04 | 616 | 197 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | FAF2 PIK3R1 MAD1L1 CPNE3 HSD3B1 HSD3B2 COL15A1 HDAC6 RUNX1 ZIC2 SF3B1 ARID2 | 9.47e-04 | 616 | 197 | 12 | C0376358 |
| Disease | risky sexual behaviour measurement | 9.87e-04 | 169 | 197 | 6 | EFO_0007877 | |
| Disease | chronic kidney disease | 1.06e-03 | 235 | 197 | 7 | EFO_0003884 | |
| Disease | holoprosencephaly (is_implicated_in) | 1.21e-03 | 8 | 197 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Congenital Hand Deformities | 1.21e-03 | 8 | 197 | 2 | C0018566 | |
| Disease | Squamous cell carcinoma of lung | 1.26e-03 | 32 | 197 | 3 | C0149782 | |
| Disease | sugar consumption measurement | 1.29e-03 | 120 | 197 | 5 | EFO_0010158 | |
| Disease | obese body mass index status | 1.38e-03 | 33 | 197 | 3 | EFO_0007041 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 1.39e-03 | 122 | 197 | 5 | EFO_0004318, EFO_0007789 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.44e-03 | 123 | 197 | 5 | EFO_0007789, EFO_0008002 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 1.55e-03 | 9 | 197 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | thoracic aortic calcification measurement | 1.55e-03 | 9 | 197 | 2 | EFO_0010273 | |
| Disease | Ovarian Cysts | 1.64e-03 | 35 | 197 | 3 | C0029927 | |
| Disease | Corpus Luteum Cyst | 1.64e-03 | 35 | 197 | 3 | C0010093 | |
| Disease | Drugs used in diabetes use measurement | 1.69e-03 | 255 | 197 | 7 | EFO_0009924 | |
| Disease | Malignant Neoplasms | 1.72e-03 | 128 | 197 | 5 | C0006826 | |
| Disease | serum metabolite measurement | TNIK PKD1L1 ITGAM CDKAL1 ALMS1 NFATC1 PTPRN2 IL33 CA12 DOK7 RUNX1 C2orf78 MSRA LRPPRC TENM3 | 1.79e-03 | 945 | 197 | 15 | EFO_0005653 |
| Disease | N6-acetyllysine measurement | 1.93e-03 | 10 | 197 | 2 | EFO_0800036 | |
| Disease | Holoprosencephaly sequence | 1.93e-03 | 10 | 197 | 2 | cv:C0079541 | |
| Disease | orofacial cleft | 1.93e-03 | 37 | 197 | 3 | MONDO_0000358 | |
| Disease | body weights and measures | 2.08e-03 | 38 | 197 | 3 | EFO_0004324 | |
| Disease | smoking status measurement | TBRG4 TSHZ2 STK17B ANO5 SP8 SEMA6D ALMS1 CSRNP3 TULP4 PTPRN2 MAD1L1 ASCC3 SERTM1 RFX3 MSRA LRPPRC PPP2R2C | 2.09e-03 | 1160 | 197 | 17 | EFO_0006527 |
| Disease | Nonsyndromic Deafness | 2.15e-03 | 81 | 197 | 4 | C3711374 | |
| Disease | skin pigmentation measurement | 2.31e-03 | 137 | 197 | 5 | EFO_0007009 | |
| Disease | response to radiation, breast carcinoma | 2.34e-03 | 11 | 197 | 2 | EFO_0000305, GO_0009314 | |
| Disease | N-acetylphenylalanine measurement | 2.34e-03 | 11 | 197 | 2 | EFO_0800019 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 2.34e-03 | 11 | 197 | 2 | C1335302 | |
| Disease | campesterol measurement | 2.34e-03 | 11 | 197 | 2 | EFO_0020008 | |
| Disease | testicular carcinoma | 2.41e-03 | 40 | 197 | 3 | EFO_0005088 | |
| Disease | Profound Mental Retardation | 2.46e-03 | 139 | 197 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.46e-03 | 139 | 197 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.46e-03 | 139 | 197 | 5 | C0917816 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.80e-03 | 12 | 197 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | craniosynostosis (is_implicated_in) | 2.80e-03 | 12 | 197 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | N-acetyl-2-aminooctanoate measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0800567 | |
| Disease | granulins measurement | 2.80e-03 | 12 | 197 | 2 | EFO_0008141 | |
| Disease | creatinine measurement | PPM1J CILP2 ALMS1 NFATC1 PIK3R1 CPNE3 ASCC3 ADGRL2 MYH7B ACAD10 CUBN CEMIP MSRA ADAMTS7 CSPG4 | 2.92e-03 | 995 | 197 | 15 | EFO_0004518 |
| Disease | longevity | 3.09e-03 | 284 | 197 | 7 | EFO_0004300 | |
| Disease | cleft lip | 3.09e-03 | 284 | 197 | 7 | EFO_0003959 | |
| Disease | unipolar depression | KCNH8 MYO10 STK17B AK9 PTCH1 CDKAL1 ENO4 FASN FAT1 SEMA6D MAD1L1 ASCC3 DMRT1 OPA1 MSRA NBAS SF3B1 | 3.11e-03 | 1206 | 197 | 17 | EFO_0003761 |
| Disease | rosacea severity measurement | 3.13e-03 | 147 | 197 | 5 | EFO_0009180 | |
| Disease | grey matter volume measurement | 3.17e-03 | 44 | 197 | 3 | EFO_0005420 | |
| Disease | IGFBP-1 measurement | 3.30e-03 | 13 | 197 | 2 | EFO_0005118 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 3.30e-03 | 13 | 197 | 2 | C1846647 | |
| Disease | hyperglycemia (is_marker_for) | 3.30e-03 | 13 | 197 | 2 | DOID:4195 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 3.32e-03 | 215 | 197 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | cortical thickness | TNIK PALD1 PRTG STK17B SIDT1 BTBD1 PTCH1 ENO4 PLEKHG1 SP8 PIK3R1 NFIX MSRA SF3B1 ADAMTS7 EPHA3 | 3.39e-03 | 1113 | 197 | 16 | EFO_0004840 |
| Disease | selective IgA deficiency disease | 3.60e-03 | 46 | 197 | 3 | EFO_1001929 | |
| Disease | waist-hip ratio | TSHZ2 CDKAL1 OLFML2A SP8 MFAP2 HOXC4 NFIX CIBAR2 COL15A1 DNAH10 LAMA4 RUNX1 TFAP2B CEMIP ABHD5 WDR11 EPHA3 | 3.67e-03 | 1226 | 197 | 17 | EFO_0004343 |
| Disease | Pneumoconiosis | 3.83e-03 | 14 | 197 | 2 | C0032273 | |
| Disease | Bagassosis | 3.83e-03 | 14 | 197 | 2 | C0004681 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 3.83e-03 | 14 | 197 | 2 | EFO_0004736, GO_0031427 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.83e-03 | 14 | 197 | 2 | DOID:898 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSAEPQLYGNATSDH | 341 | O95429 | |
| YTIQSELGDYDPELH | 331 | P11171 | |
| PHSQGEYDVYSTFQS | 61 | Q9Y2T4 | |
| SDDTPHQSYDNLNYI | 256 | P26439 | |
| VYGHYDTRLLANTSP | 226 | Q6ZTR7 | |
| PGYINFSYENSHSQA | 26 | Q99218 | |
| SIYSPHTGIQEYQDG | 211 | Q9Y646 | |
| NPNIEDIYGNTALHY | 126 | Q8IVF6 | |
| QLAYSQSADPYSHLG | 66 | Q92754 | |
| QSADPYSHLGEAYAA | 71 | Q92754 | |
| LNSNTYSSAYPLHDG | 241 | Q75V66 | |
| DQYPTHTSNRGVLSY | 301 | Q6UVK1 | |
| SVSYTGYRASAHQPE | 231 | A6NCI8 | |
| HEEYSNGALSILQYP | 461 | Q9NZJ5 | |
| ISDDTPHQSYDNLNY | 256 | P14060 | |
| LESGYHQHSPETYIQ | 236 | O60729 | |
| LYSGDPQDQLAVAYH | 311 | P54646 | |
| ETVINTANYHDTSPY | 246 | O94910 | |
| TISPSDTYYHAGVNL | 241 | P31997 | |
| IGEVDENYAPIHTYQ | 86 | P54756 | |
| EAIIANANYHDTSPY | 241 | Q9HAR2 | |
| SYSHREKPGTFYQQE | 621 | Q8TCU4 | |
| FYQQSLPGSHLTEEA | 1391 | Q8TCU4 | |
| AIPSSYNYQQHSVSD | 126 | Q68CP9 | |
| TAQNLHNSYYSVPEL | 276 | Q16589 | |
| LHYISPNGVNEYLTA | 311 | O75131 | |
| FDHGQSNPTYYIRLA | 291 | Q6JQN1 | |
| PHSRGEYNVYSTFQS | 71 | Q66LE6 | |
| GEAIINYANYHDTSP | 241 | O95490 | |
| ISYSPYISHSAGDRQ | 331 | Q6H8Q1 | |
| HGANLNFEDPVTYYT | 91 | Q9NWX5 | |
| LESGYHQHSPETYIQ | 206 | A4D256 | |
| FINLPYSTNIYEHSP | 236 | Q9H251 | |
| EGALTRSTHYQQYQP | 1031 | Q8WUJ3 | |
| ATDSSYYTNQQHPAG | 61 | Q07687 | |
| QESNPGVHYEYTIHR | 796 | Q9UKP4 | |
| QSQDPYSHVNDPYSL | 81 | Q92481 | |
| FLGVLPHYNYSEALT | 786 | O95803 | |
| ETGDTLYAPYSTHFQ | 311 | Q8NFJ5 | |
| LYQVVAQHSYSAQGP | 401 | Q86UR1 | |
| TFPHSSYSVYIAENN | 451 | Q9Y5G6 | |
| NDHGTQYRSAIYPTS | 151 | Q9UJ68 | |
| PDEGSNLYHIYEVNL | 861 | Q92932 | |
| SDNTPEHYLVQGRYF | 86 | Q9ULE6 | |
| YEHYDFSAQPPVALT | 486 | P30203 | |
| GYVTYSIANLNHVPF | 496 | Q14517 | |
| DPNIPDEYGNTTLHY | 231 | A5A3E0 | |
| PISNYYVDSLISHDN | 6 | P31274 | |
| TFPHSSYSVYVLENN | 451 | Q9Y5G7 | |
| TEVLNEYFYSHLSNP | 256 | P40425 | |
| YLEGKSSNQIYETHP | 46 | A4D1F6 | |
| DLYLAYFVHTPESGQ | 176 | Q14938 | |
| HVSYIQDETIPGYSE | 731 | P78559 | |
| ENQYRLTSLYAEHPG | 646 | Q9Y6D9 | |
| HYTPNAGDTTVLQYD | 231 | P50579 | |
| AYSFYNIHTETPLLD | 421 | O60551 | |
| SGIINHEAYHEVPYT | 571 | Q8TD19 | |
| DSSPVEHYNVHNLYG | 1426 | Q2M2H8 | |
| YNIPLENYASGSDHL | 961 | Q96NW7 | |
| LYAHIQYEGFTPSAE | 226 | A6NEK1 | |
| ESGYYSQAPAQVHQF | 86 | Q9BUM1 | |
| TQYEGHVNNSAYLPV | 306 | Q8NA75 | |
| NSSTLYYQIDSHIPG | 431 | Q8WYN3 | |
| IVHYNSDLYPDASTA | 146 | O43570 | |
| FAYNQITDTEGISHP | 141 | Q53EV4 | |
| SPPHIYAVADNAYND | 191 | A7E2Y1 | |
| NSLGVNPYINHLYSD | 406 | Q14651 | |
| VSSPHYSTNGNYDGV | 326 | Q13608 | |
| SYHPIPQENTGVEDY | 376 | Q6P3R8 | |
| FPNHYSIVTGLYEES | 71 | Q9Y6X5 | |
| LYGSIHPADSVYLST | 151 | Q5QP82 | |
| NNADGTYHITYSPAF | 1206 | Q14315 | |
| QHPQYITLHDTYESP | 2736 | O60229 | |
| EEEHYGYASSNVSPA | 41 | O95644 | |
| YEHILSFGAPLANTY | 1996 | Q9HD67 | |
| QELGVHPDQETYTDY | 466 | P42704 | |
| RPYSSYHLEVQAFNG | 886 | P32004 | |
| QEAYGSAQHLPYSEV | 1576 | Q6ZVL6 | |
| YTGPTQEDLYLHVNS | 221 | Q9BRP0 | |
| HNDSLNVTLAYPVYA | 706 | P27986 | |
| PYVDHYDHTIENNTE | 81 | Q9BZM2 | |
| AESEGTYDTYQHVPV | 1486 | A2RRP1 | |
| YTAHFLQAGYDVPTI | 506 | Q8WXE0 | |
| PNGVTYHTGTYQDRL | 61 | Q96HR3 | |
| HANQTGYPDPSSRYD | 331 | P16112 | |
| PSFTEAHQYNIYGSS | 746 | Q8N475 | |
| THYIIDDLEPASNYT | 476 | Q2VWP7 | |
| DPNIPDEYGNTTLHY | 231 | Q6S8J3 | |
| SDYDASYNTQDHLPR | 276 | O60313 | |
| DYLAVYDGPSSNSHL | 1221 | O60494 | |
| PQNASTYSAIGYIHS | 476 | Q13042 | |
| HLYDTPGSTYNLQIL | 981 | Q9ULT8 | |
| LSYYESQHPSNESGD | 161 | O95760 | |
| HPTTNNILFSAGYDY | 146 | Q9UQ03 | |
| EGVAQTSFYSQPDHL | 156 | P06340 | |
| IQDNHDGTYTVAYVP | 1596 | P21333 | |
| GEAAASQLILYHYPE | 231 | Q5TC12 | |
| SYSPYDHKIGERQQV | 426 | Q5VV42 | |
| NLNQDAPDTYHYVVS | 76 | P24855 | |
| KTYVDPHTYEDPNQA | 586 | P29317 | |
| QHQTLENGYDVYHSP | 116 | Q9GZV9 | |
| LYGSIHGPTDYQVNI | 366 | Q9H0C5 | |
| AIGVNSPYQLIYHSS | 216 | Q8ND61 | |
| SNQYNIYAALHTEPD | 746 | Q6MZW2 | |
| YAAYDQNITPLHTDF | 496 | Q96SY0 | |
| QVPGRYHELYQQSDT | 911 | Q8NCU4 | |
| GPYFYDLTVTSAHDQ | 3016 | P12111 | |
| EEYSQNSYIPEHSPE | 21 | P09017 | |
| SGVDEHYTPIRTYQV | 56 | P29320 | |
| GYEPNYNRTASAHSV | 2281 | Q99698 | |
| PTAGHTLYSVLSQGY | 501 | Q9HBG7 | |
| DNTAQTSAYIQYEPH | 926 | O75578 | |
| NSTFYLQPADVYGHL | 41 | A6NNW6 | |
| QIYIAGHPAFVNYST | 161 | P14866 | |
| QERFTQDTQPHYIYS | 2781 | Q14204 | |
| LSSYHLDGLEPATQY | 916 | Q02388 | |
| NSVDQHENSYYPRGD | 486 | Q9NRM1 | |
| PTVRHYEGEQYTSNQ | 681 | Q9NRM1 | |
| DLDPYNSPGQEVYHA | 651 | Q96PD2 | |
| DIPHYDYLTSQTREA | 3351 | Q8NDH2 | |
| GTVEYQVPTSLRAHY | 391 | Q18PE1 | |
| VLADTYDSVYLHPNS | 166 | Q9UBN7 | |
| HYTGQPGYLSDTETS | 561 | Q8IYK4 | |
| PYAAHLYDAENTQTP | 111 | Q6UWX4 | |
| IYNIDTSSESPDHYL | 861 | P49327 | |
| NKGSYSLSHVYTPND | 256 | P07686 | |
| LYYTEPGSHVSQEAA | 136 | P39059 | |
| HPNAEIGYYTQAARD | 4161 | Q8IVF4 | |
| QDGTVTPTHYNVIYD | 806 | Q7Z3Z3 | |
| TPTHYNVIYDTIGLS | 811 | Q7Z3Z3 | |
| VYRGDPYSAHNSTEF | 346 | Q9UMX9 | |
| ILPSHTLEYGNYTAL | 741 | Q8TDX9 | |
| HVENTPDLVSDSTYY | 196 | Q9Y5R6 | |
| DHVQYTHYSDQIDNP | 31 | P55001 | |
| HINATALLEYPEYSG | 456 | Q969Z0 | |
| FLNEHAYTTQIDYNP | 616 | Q68BL7 | |
| NSPRAIEHAYQYGGT | 1461 | Q16363 | |
| DQNIPDEYGNTTLHY | 231 | B2RU33 | |
| YITSEHSYQKPQSFG | 856 | A8MW92 | |
| VQDRNGHEGYVPSSY | 211 | Q08881 | |
| DVDSGNSYDIYIPVH | 1191 | Q8N4C8 | |
| DRNIPDEYGNTALHY | 231 | Q86YR6 | |
| SGSVSPTHYNVIYDN | 786 | Q96J94 | |
| QSYQYLGSIASPSVH | 256 | Q01196 | |
| TTAEEFYQSLGIPYH | 346 | P49591 | |
| QYAGIPSVNSLHSVY | 206 | P17600 | |
| EALVPGSINYALEYH | 1741 | Q5TCS8 | |
| YIPLYTGHVQSTNAD | 321 | A4D263 | |
| VEVYLSDAPSHYSQD | 1021 | O15034 | |
| VSIYDNVPGSHLYAS | 456 | Q9Y3M8 | |
| ESQQAELYYTLHAPD | 226 | Q6IEE7 | |
| ALEISENAYGADHPY | 1011 | Q7Z494 | |
| HVYPAQVQYVEGSDT | 51 | P48380 | |
| GAQNEPVVYHGYTLT | 206 | Q86YW0 | |
| ERPGAQVTYSLHLYS | 2621 | Q6ZNJ1 | |
| HPVFYQGTYSQALND | 151 | Q96CS3 | |
| SINYYFINSQGHPIE | 311 | Q9NPR9 | |
| VLSAYEPNDHSRYTA | 446 | Q5JR12 | |
| NIPDEYGNTTLHYAI | 196 | P0CG39 | |
| EPQAYTDTHDNTRYS | 626 | Q13635 | |
| HTSPFVGEDNQETYL | 231 | O94768 | |
| TVYEYDPEGHLTNAT | 1651 | Q9UKZ4 | |
| DPNIPDEYGNTTLHY | 231 | P0CG38 | |
| VDPSSGHLSNVYIYV | 31 | A2A2V5 | |
| GGLQTSQIHYSYNEE | 71 | Q9BVR0 | |
| STDLVLIGAPHYYEQ | 471 | P11215 | |
| YYNSHSHSGEENLNP | 696 | O94993 | |
| QTSLHSPLGGYNSDY | 241 | Q8IXZ3 | |
| TEYIYHCNVQTPSGE | 246 | Q8WTS1 | |
| PNIVDVYGNTAVHYA | 131 | A7E2S9 | |
| NPSYYNLGDVSHDSV | 1766 | Q8N3C0 | |
| GHNYGIYTVTDQDPR | 1071 | O75339 | |
| GHNYGVYTVTDQSPR | 1056 | Q8IUL8 | |
| KSTYNVNHPNYGTVD | 501 | Q8TBB6 | |
| GQHYASISVPGSYIN | 441 | O75443 | |
| LPRAYNHYSQGSDLA | 116 | Q2L4Q9 | |
| HAGDSATQYPVSNRY | 736 | Q9NRJ4 | |
| DSGNSYDIYIPSHIQ | 1221 | Q9UKE5 | |
| PTEASYEDGYSVSHQ | 266 | Q92574 | |
| YEITAYLEAAGIHNP | 1011 | Q12768 | |
| TYNTGQTVVAFHSPY | 2201 | Q96RL7 | |
| PQRFYSSEHEYSGLN | 61 | Q14CS0 | |
| VSYERHPSQYDNISG | 476 | Q13905 | |
| EDSLEHNYYNSIPGK | 331 | P98077 | |
| SIYIGSQDALIAHYP | 1271 | O75533 | |
| PEQGYDRPYEDSSQH | 306 | Q15532 | |
| NYQGYSQETVPKDHL | 771 | Q6ZQQ2 | |
| QTRHPDINASAYSAY | 591 | Q9NXL6 | |
| QYFLLSSQVGLHPEY | 251 | Q93063 | |
| HNGTPLTNYYQLSLD | 136 | P20061 | |
| LPTNYSLTYHREGET | 56 | P16471 | |
| HEESPPQYQTSYLQS | 2691 | P21359 | |
| TYEHYANSTQPGEPR | 66 | P55017 | |
| TYNTSGYILDPHTAV | 631 | Q8IYQ7 | |
| IIYASGLDSHYQTEP | 1706 | Q9P273 | |
| PQHYPSIHITAYEND | 631 | Q4J6C6 | |
| HYQGQVSFLDPSYSL | 81 | Q96A28 | |
| YPSIHAAYQLSEGTK | 541 | Q9NRE2 | |
| SSYNNVYLAVADTHP | 596 | Q5HYM0 | |
| GAVRNFSPTDYYHSE | 101 | Q9BZ95 | |
| EQYGQVTSPRSEHYA | 176 | Q15915 | |
| ENGVTHPIDYHTTDY | 231 | Q99536 | |
| EYNEPVKSYGNSSSH | 166 | Q5MCW4 | |
| QATPDHGYLSLLYDS | 801 | Q9ULL1 | |
| AYLQSITPQGYSDSE | 1111 | O60315 | |
| GQYSLDISHVDYPEN | 866 | Q9BZH6 | |
| VDHSAGPYQNYTVIF | 426 | Q8NFY4 | |
| HEPRTFAVYLNNTGY | 121 | Q8IWU6 | |
| DPNIPDEYGNTALHY | 231 | Q6S5H5 | |
| DPNIPDEYGNTALHY | 231 | A6NI47 | |
| SALLGDHYVQLPATY | 1346 | Q04912 | |
| QYLQSYGPEHLLTFS | 421 | Q9H267 | |
| RTDPYSAAQLHNQYG | 201 | O95409 | |
| LDYSPSHYQVVQEGH | 991 | Q96L42 |